1-5 of 5
Eva Mikuskova
Close
Sort by
Journal Articles

ASP210 - a Potent Oligonucleotide-Based Inhibitor for Combating Both BCR-ABL1 Dependent and Independent TKI-Resistant CML Cells

Veronika Nemethova, Petra Mazancova, Boglarka Nemethova, Lucia Uhelska, Andrea Babelova, Michal Selc, Kristina Jakic, Ondrej Mitrovsky, Denisa Myslivcova, Marketa Zackova, Alexandra Poturnayova, Angelika Batorova, Antonia Hatalova, Katarina Slezakova, Lubos Drgona, Iveta Oravcova, Eva Mikuskova, Ludmila Demitrovicova, Andrej Vranovsky, Filip Razga
Journal: Blood
Blood (2022) 140 (Supplement 1): 12995–12996.
https://doi.org/10.1182/blood-2022-166148
Published: 2022
Journal Articles

Obinutuzumab Alone or Combined with Chemotherapy in Previously Untreated (Fit or Unfit) or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients: Final Results from the Phase IIIb GREEN Safety Study with a Focus on Efficacy

Stephan Stilgenbauer, MD, Francesc Bosch, MD PhD, Véronique Leblond, MD PhD, Osman Ilhan, MD, Jens Kisro, Béatrice Mahé, MD, Eva Mikuskova, MD PhD, Dzhelil Osmanov, MD, Gianluigi Reda, MD, Eugen Tausch, Marcin Wójtowicz, MD PhD, Thomas Perretti, MD MSc, Marlies EHM Van Hoef, MD PhD MBA, Robin Foà, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3035.
https://doi.org/10.1182/blood-2019-123419
Published: 2019
Journal Articles

Treatment Outcomes in Patients Treated with Tyrosine Kinase Inhibitors in "Slovak Registry of Chronic Myeloid Leukemia" (CAMELIA SK)

Zuzana Sninska, MD PhD, Martin Mistrik, MD PhD, Ass. Prof., Katarina Slezakova, MD PhD, Ludmila Demitrovicova, MD, Eva Mikuskova, MD PhD, Imrich Markuljak, MD, Juraj Chudej, MD PhD, Natalia Stecova, MD, Elena Tothova, Prof, MD PhD, Adriana Kafkova, MD PhD, Stanislav Palasthy, MD, Jana Lesko-Andrascikova, MD, Tereza Necasova, Bc, Eva Koritakova, RNDr
Journal: Blood
Blood (2016) 128 (22): 3087.
https://doi.org/10.1182/blood.V128.22.3087.3087
Published: 2016
Journal Articles

Safety and Efficacy of Obinutuzumab Plus Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the Green Study

Stephan Stilgenbauer, MDPhD, Osman Ilhan, Darius Woszczyk, Christoph Renner, Eva Mikuskova, Sebastian Böttcher, MD, Eugen Tausch, MD, Tom Moore, Nicola Tyson, Helena Adamis, Véronique Leblonde, Francesc Bosch, Robin Foà
Journal: Blood
Blood (2015) 126 (23): 493.
https://doi.org/10.1182/blood.V126.23.493.493
Published: 2015
Journal Articles

Rituximab Maintenance after Chemoimmunotherapy Induction in 1 st and 2 nd Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial

Richard Greil, MD, Petra Obrtlikova, MD PhD, Lukas Smolej, MD PhD, Tomas Kozak, MDPhD, Michael Steurer, MD, Johannes Andel, MD, Josef Thaler, MD, Eva Mikuskova, MD, Liana Gercheva, MD, Thomas Nösslinger, MD, Miriam Ladicka, MD, Michael Girschikofsky, MD, MikulᚠHrubiško, MD PhD, Prof., Ulrich Jäger, MD, Michael A. Fridrik, MD, Martin Pecherstorfer, MD, Eva Kralikova, MD, Cristina Burcoveanu, MD, Stefcho Goranov, MD, Jana Jurkovikova, MD, Andreas L. Petzer, MD, Georgi G. Mihaylov, MD PhD, Julian Raynov, MD, Horst Oexle, MD, August Zabernigg, MD, Emilia Flochova, MD PhD, Stanislav Palasthy, MD, Thomas Melchardt, MD, Jiri Mayer, MD, Alexander Egle, MD
Journal: Blood
Blood (2014) 124 (21): 20.
https://doi.org/10.1182/blood.V124.21.20.20
Published: 2014